Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Гестационный сахарный диабет

Список литературы

  1. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD: Hyperglycemia and adverse pregnancy outcomes. Obstetric Anesthesia Digest 2009, 29(1):39-40.
  2. Fetita L-S, Sobngwi E, Serradas P, Calvo F, Gautier J-F: Consequences of fetal exposure to maternal diabetes in offspring. The Journal of Clinical Endocrinology & Metabolism 2006, 91(10):3718-3724.
  3. Lowe Jr WL, Scholtens DM, Kuang A, Linder B, Lawrence JM, Lebenthal Y, McCance D, Hamilton J, Nodzenski M, Talbot O: Hyperglycemia and adverse pregnancy outcome follow-up study (HAPO FUS): maternal gestational diabetes mellitus and childhood glucose metabolism. Diabetes care 2019, 42(3):372-380.
  4. Metzger B, Oats J, Coustan D, Hod M: Results of the HAPO study: progress towards a new paradigm for detection & diagnosis of GDM. In: 5th Intrnational symposium on diabetes and pregnancy Italy, Sorrento: 2009; 2009.
  5. Consultation W: Definition, diagnosis and classification of diabetes mellitus and its complications. In.: Part; 1999.
  6. Metzger BE, Gabbe SG, Persson B, Lowe LP, Dyer AR, Oats JJ, Buchanan TA: International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy: response to Weinert. Diabetes care 2010, 33(7):e98-e98.
  7. Дедов И.И., Краснопольский В.И., Г.Т. С: Российский национальный консенсус «Гестационный сахарный диабет: диагностика, лечение, послеродовое наблюдение». Сахарный диабет 2012(4):4-10.
  8. López Stewart G: Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: A World Health Organization Guideline. 2014.
  9. Federation ID. IDF Diabetes Atlas. 9th edition Brussels BIDF.
  10. Webber J, Charlton M, Johns N: Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period (NG3). British Journal of Diabetes 2015, 15(3):107-111.
  11. McIntyre HD, Sacks DA, Barbour LA, Feig DS, Catalano PM, Damm P, McElduff A: Issues with the diagnosis and classification of hyperglycemia in early pregnancy. Diabetes care 2016, 39(1):53-54.
  12. Zhu W-w, Yang H-x, Wei Y-m, Yan J, Wang Z-l, Li X-l, Wu H-r, Li N, Zhang M-h, Liu X-h: Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in China. Diabetes care 2013, 36(3):586-590.
  13. Corrado F, D’Anna R, Cannata M, Interdonato ML, Pintaudi B, Di Benedetto A: Correspondence between first-trimester fasting glycaemia, and oral glucose tolerance test in gestational diabetes diagnosis. Diabetes & metabolism 2012, 38(5):458-461.
  14. Bozkurt L, Göbl CS, Pfligl L, Leitner K, Bancher-Todesca D, Luger A, Baumgartner-Parzer S, Pacini G, Kautzky-Willer A: Pathophysiological characteristics and effects of obesity in women with early and late manifestation of gestational diabetes diagnosed by the International Association of Diabetes and Pregnancy Study Groups criteria. The Journal of Clinical Endocrinology & Metabolism 2015, 100(3):1113-1120.
  15. Group HSCR: Hyperglycemia and adverse pregnancy outcomes: the HAPO study cooperative research group. Obstetrical & Gynecological Survey 2008, 63(10):615-616.
  16. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS: Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New England journal of medicine 2005, 352(24):2477-2486.
  17. Landon MB: Obstetric management of pregnancies complicated by diabetes mellitus. Clinical obstetrics and gynecology 2000, 43(1):65-74.
  18. Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE: Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes care 2007, 30.
  19. Riskin-Mashiah S, Younes G, Damti A, Auslender R: First-trimester fasting hyperglycemia and adverse pregnancy outcomes. Diabetes care 2009, 32(9):1639-1643.
  20. Дерябина Е.Г., Башмакова Е.В., Ларькин Д.М: Роль раннего скрининга гестационного сахарного диабета для оптимизации перинатальных исходов. Акушерство и гинекология 2013(9):13-17.
  21. Allen VM, Armson BA, Wilson RD, Blight C, Gagnon A, Johnson J-A, Langlois S, Summers A, Wyatt P, Farine D: RETIRED: Teratogenicity Associated With Pre-Existing and Gestational Diabete. Journal of Obstetrics and Gynaecology Canada 2007, 29(11):927-934.
  22. Callec R, Perdriolle-Galet E, Sery G-A, Morel O: Type 2 diabetes in pregnancy: Rates of fetal malformations and level of preconception care. Journal of Obstetrics and Gynaecology 2014, 34(7):648-649.
  23. Peterson CM, Jovanovic L: Glycosylated proteins in normal and diabetic pregnancy. European Journal of Endocrinology 1986, 113(3_Supplement):S107-S111.
  24. Wender-Ożegowska E, Wroblewska K, Zawiejska A, Pietryga M, Szczapa J, Biczysko R: Threshold values of maternal blood glucose in early diabetic pregnancy-prediction of fetal malformations. Acta obstetricia et gynecologica Scandinavica 2005, 84(1):17-25.
  25. Силко ЮВ НТ, Иванова ОН, и др. : Латентный аутоиммунный диабет взрослых: информативность аутоантител. . Терапевтический архив (архив до 2018 г) (2016;88(10):42–45. ).
  26. Sosenko JM SJ, Palmer JP, et al.: The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients. . Diabetes Care, 2013;36(9):2615–2620.
  27. Salonen K, Ryhänen S, Härkönen T, Ilonen J, Knip M, Register FPD: Autoantibodies against zinc transporter 8 are related to age, metabolic state and HLA DR genotype in children with newly diagnosed type 1 diabetes. Diabetes/metabolism research and reviews 2013, 29(8):646-654.
  28. Andersson C, Vaziri‐Sani F, Delli A, Lindblad B, Carlsson A, Forsander G, Ludvigsson J, Marcus C, Samuelsson U, Ivarsson S: Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes. Pediatric diabetes 2013, 14(2):97-105.
  29. Клинические рекомендации "Сахарный диабет 1 типа у взрослых". 2022.
  30. 2. Diagnosis and classification of diabetes: standards of care in diabetes—2024. Diabetes Care 2024, 47(Supplement_1):S20-S42.
  31. Hanna FW, Duff CJ, Shelley-Hitchen A, Hodgson E, Fryer AA: Diagnosing gestational diabetes mellitus: implications of recent changes in diagnostic criteria and role of glycated haemoglobin (HbA1c). Clinical Medicine 2017, 17(2):108-113.
  32. Волкова Н. И. ПСО: Гестационный сахарный диабет: проблемы современного скрининга Сахарный диабет 2022, Т. 25. – №. 1. – С. 72-80.
  33. Zhu W-w, Fan L, Yang H-x, Kong L-y, Su S-p, Wang Z-l, Hu Y-L, Zhang M-h, Sun L-Z, Mi Y: Fasting plasma glucose at 24–28 weeks to screen for gestational diabetes mellitus: new evidence from China. Diabetes care 2013, 36(7):2038-2040.
  34. Benhalima K, Minschart C, Ceulemans D, Bogaerts A, Van Der Schueren B, Mathieu C, Devlieger R: Screening and management of gestational diabetes mellitus after bariatric surgery. Nutrients 2018, 10(10):1479.
  35. Дедов И, Шестакова М, Майоров А: Клинические рекомендации. Сахарный диабет 2 типа у взрослых. Сахарный диабет 2020, 23(S2):4102.
  36. Петеркова В, Безлепкина О, Лаптев Д, Кураева Т, Майоров А, Титович Е, Емельянов А, Светлова Г, Еремина И, Алимова И: Клинические рекомендации сахарный диабет 1 типа у детей. In: Достижения науки в клиническую практику детского эндокринолога и педиатра: 2022; 2022: 5-80.
  37. Kintiraki E, Goulis DG: Gestational diabetes mellitus: Multi-disciplinary treatment approaches. Metabolism 2018, 86:91-101.
  38. Скворцова МВ. Приказ Министерства здравоохранения Российской Федерации от 1 ноября 2012 г. № 572н" Об утверждении Порядка оказания медицинской помощи по профилю" акушерство и гинекология (за исключением использования вспомогательных репродуктивных технологий)". Российская газета. 2013.
  39. Brown J, Alwan NA, West J, Brown S, McKinlay CJ, Farrar D, Crowther CA: Lifestyle interventions for the treatment of women with gestational diabetes. Cochrane Database of Systematic Reviews 2017(5).
  40. Viana LV, Gross JL, Azevedo MJ: Dietary intervention in patients with gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials on maternal and newborn outcomes. Diabetes care 2014, 37(12):3345-3355.
  41. Peterson CM, Jovanovic-Peterson L: Percentage of carbohydrate and glycemic response to breakfast, lunch, and dinner in women with gestational diabetes. Diabetes 1991, 40(Supplement_2):172-174.
  42. Lain KY, Catalano PM: Metabolic changes in pregnancy. Clinical obstetrics and gynecology 2007, 50(4):938-948.
  43. Laredo-Aguilera JA, Gallardo-Bravo M, Rabanales-Sotos JA, Cobo-Cuenca AI, Carmona-Torres JM: Physical activity programs during pregnancy are effective for the control of gestational diabetes mellitus. International journal of environmental research and public health 2020, 17(17):6151.
  44. 15. Management of diabetes in pregnancy: standards of care in diabetes—2024. Diabetes Care 2024, 47(Supplement_1):S282-S294.
  45. Mendez-Figueroa H, Daley J, Lopes VV, Coustan DR: Comparing daily versus less frequent blood glucose monitoring in patients with mild gestational diabetes. The Journal of Maternal-Fetal & Neonatal Medicine 2013, 26(13):1268-1272.
  46. Sacks DA: Weekly compared with daily blood glucose monitoring in women with diet-treated gestational diabetes. Obstetrics & Gynecology 2009, 114(6):1375.
  47. de Veciana M, Major CA, Morgan MA, Asrat T, Toohey JS, Lien JM, Evans AT: Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. New England Journal of Medicine 1995, 333(19):1237-1241.
  48. Mendez-Figueroa H, Schuster M, Maggio L, Pedroza C, Chauhan SP, Paglia MJ: Gestational diabetes mellitus and frequency of blood glucose monitoring: a randomized controlled trial. Obstetrics & Gynecology 2017, 130(1):163-170.
  49. Laird J, McFarland KF: Fasting blood glucose levels and initiation of insulin therapy in gestational diabetes. Endocrine Practice 1996, 2(5):330-332.
  50. G Moses R, M Luca E, Knights S: Gestational diabetes mellitus. At what time should the postprandial glucose level be monitored? Australian and New Zealand journal of obstetrics and gynaecology 1999, 39(4):457-460.
  51. Sivan E, Weisz B, Homko CJ, Reece EA, Schiff E: One or two hours postprandial glucose measurements: are they the same? American journal of obstetrics and gynecology 2001, 185(3):604-607.
  52. Weisz B, Shrim A, Homko CJ, Schiff E, Epstein GS, Sivan E: One hour versus two hours postprandial glucose measurement in gestational diabetes: a prospective study. Journal of Perinatology 2005, 25(4):241-244.
  53. ГОСТ Р ИСО 15197-2015 Тест-системы для диагностики in vitro. Требования к системам мониторинга глюкозы в крови для самоконтроля при лечении сахарного диабета (электронный ресурс). [GOST R ISO 15197-2015 In vitro diagnostic test systems. Requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus. (In Russ.)] доступно по: http://docs.cntd.ru/document/1200120137. .
  54. Jang HC PJ, Yim CH, Chung HY, Han KO, Yoon HK, Han IK, Kim MY, Yang JH, Kim MJ, Ko SY, Lee YK. : Effect of Self-monitoring of Blood Glucose on Pregnancy Outcome in Women with Mild Gestational Diabetes.. . Diabetes Metab J 2001;25(1):93-102.
  55. Дедов ИИ, Сухих ГТ, Филиппов ОС, Арбатская НЮ, Боровик НВ, Бурумкулова ФФ, Галстян Г, Григорян ОР, Дегтярева ЕИ, Демидова ИЮ: Гестационный сахарный диабет: диагностика, лечение, послеродовое наблюдение. Проблемы репродукции 2018, 24(Suppl 6):115-127.
  56. Brown J, Grzeskowiak L, Williamson K, Downie MR, Crowther CA: Insulin for the treatment of women with gestational diabetes. Cochrane Database of Systematic Reviews 2017(11).
  57. Durnwald C, Nathan D, Werner E, Barss V: Gestational diabetes mellitus: Glycemic control and maternal prognosis. UpToDate www uptod ate com Accessed 2020, 27.
  58. Weinstock RS: General principles of insulin therapy in diabetes mellitus. Online Referencing 2021.
  59. Toledano Y, Hadar E, Hod M: Pharmacotherapy for hyperglycemia in pregnancy–The new insulins. Diabetes research and clinical practice 2018, 145:59-66.
  60. Bonomo M, Cetin I, Pisoni M, Faden D, Mion E, Taricco E, de Santis MN, Radaelli T, Motta G, Costa M: Flexible treatment of gestational diabetes modulated on ultrasound evaluation of intrauterine growth: a controlled randomized clinical trial. Diabetes & metabolism 2004, 30(3):237-243.
  61. Kjos SL, Schaefer-Graf U, Sardesi S, Peters RK, Buley A, Xiang AH, Bryne JD, Sutherland C, Montoro MN, Buchanan TA: A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes care 2001, 24(11):1904-1910.
  62. García‐Moreno RM, Benítez‐Valderrama P, Barquiel B, González Pérez‐de‐Villar N, Hillman N, Lora Pablos D, Herranz L: Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta‐analysis of randomized clinical trials. Diabetic Medicine 2022, 39(1):e14703.
  63. Majewska A, Stanirowski PJ, Tatur J, Wojda B, Radosz I, Wielgos M, Bomba-Opon DA: Flash glucose monitoring in gestational diabetes mellitus (FLAMINGO): a randomised controlled trial. Acta Diabetologica 2023, 60(9):1171-1177.
  64. Rademaker D, van Der Wel AW, van Eekelen R, Voormolen DN, de Valk HW, Evers IM, Mol BW, Franx A, Siegelaar SE, van Rijn BB: Continuous glucose monitoring metrics and pregnancy outcomes in insulin‐treated diabetes: A post‐hoc analysis of the GlucoMOMS trial. Diabetes, Obesity and Metabolism 2023, 25(12):3798-3806.
  65. Bastobbe S, Heimann Y, Schleußner E, Groten T, Weschenfelder F: Using flash glucose monitoring in pregnancies in routine care of patients with gestational diabetes mellitus: a pilot study. Acta Diabetologica 2023, 60(5):697-704.
  66. Kaymak O, İskender D, Danışman N: Comparison of one hour versus 90 minute postprandial glucose measurement in women with gestational diabetes; which one is more effective? Journal of Obstetrics and Gynaecology 2022, 42(3):447-451.
  67. Kautzky-Willer A, Harreiter J, Winhofer-Stöckl Y, Bancher-Todesca D, Berger A, Repa A, Lechleitner M, Weitgasser R: Gestational diabetes mellitus (Update 2019). Wiener Klinische Wochenschrift 2019, 131:91-102.
  68. Sacks DA: Etiology, detection, and management of fetal macrosomia in pregnancies complicated by diabetes mellitus. Clinical obstetrics and gynecology 2007, 50(4):980-989.
  69. Schäfer-Graf U, Wöckel A: Severe diabetic fetopathy due to undiagnosed gestational diabetes mellitus. Deutsche Medizinische Wochenschrift (1946) 2006, 131(20):1151-1154.
  70. Лысенко СН: Особенности формирования диабетической фетопатии: диагностика и оптимизация акушерской тактики. Москва 2019.
  71. Moon-Grady AJ, Donofrio MT, Gelehrter S, Hornberger L, Kreeger J, Lee W, Michelfelder E, Morris SA, Peyvandi S, Pinto NM: Guidelines and recommendations for performance of the fetal echocardiogram: an update from the American Society of Echocardiography. Journal of the American Society of Echocardiography 2023, 36(7):679-723.
  72. Khalil A, Sotiriadis A, D"Antonio F, Da Silva Costa F, Odibo A, Prefumo F, Papageorghiou A, Salomon L: ISUOG Practice Guidelines: performance of third-trimester obstetric ultrasound scan. Ultrasound in Obstetrics & Gynecology 2024, 63(1):131-147.
  73. Ремнёва ОВ, Рожкова ОВ, Трухачева НВ, Брусенцов ИГ: Прогнозирование диабетической фетопатии при гестационном сахарном диабете у матери. Доктор Ру 2020, 19(6):45-49.
  74. Zöllkau J, Swiderski L, Schmidt A, Weschenfelder F, Groten T, Hoyer D, Schneider U: The relationship between gestational diabetes metabolic control and fetal autonomic regulation, movement and birth weight. Journal of Clinical Medicine 2021, 10(15):3378.
  75. Uggioni MLR, Colonetti T, Grande AJ, Cruz MVB, da Rosa MI: Corticosteroids in pregnancy for preventing RDS: overview of systematic reviews. Reproductive Sciences 2022, 29(1):54-68.
  76. Schmitz T: Prevention of preterm birth complications by antenatal corticosteroid administration. Journal de gynecologie, obstetrique et biologie de la reproduction 2016, 45(10):1399-1417.
  77. Guideline N: Diabetes in pregnancy: management from preconception to the postnatal period. Guidance NICE 2015.
  78. Boulvain M, Senat M-V, Perrotin F, Winer N, Beucher G, Subtil D, Bretelle F, Azria E, Hejaiej D, Vendittelli F: Induction of labour versus expectant management for large-for-date fetuses: a randomised controlled trial. The Lancet 2015, 385(9987):2600-2605.
  79. Boulvain M, Irion O, Thornton JG: Induction of labour at or near term for suspected fetal macrosomia. Cochrane Database of Systematic Reviews 2016(5).
  80. Melamed N, Ray JG, Geary M, Bedard D, Yang C, Sprague A, Murray-Davis B, Barrett J, Berger H: Induction of labor before 40 weeks is associated with lower rate of cesarean delivery in women with gestational diabetes mellitus. American journal of obstetrics and gynecology 2016, 214(3):364. e361-364. e368.
  81. Feghali MN, Caritis SN, Catov JM, Scifres CM: Timing of delivery and pregnancy outcomes in women with gestational diabetes. American journal of obstetrics and gynecology 2016, 215(2):243. e241-243. e247.
  82. Rosenstein MG, Cheng YW, Snowden JM, Nicholson JM, Doss AE, Caughey AB: The risk of stillbirth and infant death stratified by gestational age in women with gestational diabetes. American journal of obstetrics and gynecology 2012, 206(4):309. e301-309. e307.
  83. Beta J, Khan N, Khalil A, Fiolna M, Ramadan G, Akolekar R: Maternal and neonatal complications of fetal macrosomia: systematic review and meta‐analysis. Ultrasound in Obstetrics & Gynecology 2019, 54(3):308-318.
  84. Баев ОР, Румянцева ВП, Кан НЕ, Тетруашвили НК, Тютюнник ВЛ, Ходжаева ЗС, Адамян ЛВ, Сухих ГТ: Подготовка шейки матки к родам и родовозбуждение. Клинический протокол. Акушерство и гинекология 2012(4-2-S):14-23.
  85. Ayres-de-Campos D, Spong CY, Chandraharan E: FIGO consensus guidelines on intrapartum fetal monitoring: Cardiotocography. International Journal of Gynecology & Obstetrics 2015, 131(1):13-24.
  86. Alfirevic Z, Gyte GM, Cuthbert A, Devane D: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane database of systematic reviews 2017(2).
  87. Адамян ЛВ, Серов В: Оказание медицинской помощи при одноплодных родах в затылочном предлежании (без осложнений) и в послеродовом периоде. Проблемы репродукции 2017, 23(S3):7-26.
  88. Адамян ЛВ, Артымук НВ, Белокриницкая ТЕ, Краснопольский ВИ, Куликов АВ, Овезов АМ, Петрухин ВА, Проценко ДН, Пырегов АВ, Упрямова ЕЮ: Нейроаксиальные методы обезболивания родов. Проблемы репродукции 2018, 24(S6):501-521.
  89. de Valk HW, Visser GH: Insulin during pregnancy, labour and delivery. Best practice & research Clinical obstetrics & gynaecology 2011, 25(1):65-76.
  90. Waters TP, Kim SY, Werner E, Dinglas C, Carter EB, Patel R, Sharma AJ, Catalano P: Should women with gestational diabetes be screened at delivery hospitalization for type 2 diabetes? American journal of obstetrics and gynecology 2020, 222(1):73. e71-73. e11.
  91. Aroda V, Christophi C, Edelstein S, Zhang P, Herman W, Barrett-Connor E, Delahanty L, Montez M, Ackermann R, Zhuo X: The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. The Journal of Clinical Endocrinology & Metabolism 2015, 100(4):1646-1653.
  92. Sullivan SD, Umans JG, Ratner R: Hypertension complicating diabetic pregnancies: pathophysiology, management, and controversies. The Journal of Clinical Hypertension 2011, 13(4):275-284.
  93. Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, Hall DR, Warren CE, Adoyi G, Ishaku S: Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension 2018, 72(1):24-43.
  94. Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, McAuliffe F, da Silva Costa F, Von Dadelszen P, McIntyre HD: The International Federation of Gynecology and Obstetrics (FIGO) initiative on preeclampsia (PE): a pragmatic guide for first trimester screening and prevention. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2019, 145(Suppl 1):1.
  95. Abalos E, Duley L, Steyn DW, Gialdini C: Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane database of systematic reviews 2018(10).
  96. Ayala DE, Hermida RC: Ambulatory blood pressure monitoring for the early identification of hypertension in pregnancy. Chronobiology international 2013, 30(1-2):233-259.
  97. Sánchez-Lechuga B, Lara-Barea A, Córdoba-Doña JA, Galván AM, Cruz AA, Aguilar-Diosdado M, López-Tinoco C: Usefulness of blood pressure monitoring in patients with gestational diabetes mellitus. Endocrinología, Diabetes y Nutrición (English ed) 2018, 65(7):394-401.
  98. Рунихина Н, Михайлусова М, Барт Б: Хроническая артериальная гипертония и особенности ее течения в различные сроки беременности (по данным суточного мониторирования артериального давления). Кардиоваскулярная терапия и профилактика 2006, 5(8):11-16.
  99. Spencer L, Rollo M, Hauck Y, MacDonald-Wicks L, Wood L, Hutchesson M, Giglia R, Smith R, Collins C: The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol. JBI Evidence Synthesis 2015, 13(1):88-98.
  100. Abreu LR, Shirley MK, Castro NP, Euclydes VV, Bergamaschi DP, Luzia LA, Cruz AM, Rondo PH: Gestational diabetes mellitus, pre-pregnancy body mass index, and gestational weight gain as risk factors for increased fat mass in Brazilian newborns. PLoS One 2019, 14(8):e0221971.
  101. Hammoud NM, Visser GH, van Rossem L, Biesma DH, Wit JM, de Valk HW: Long-term BMI and growth profiles in offspring of women with gestational diabetes. Diabetologia 2018, 61:1037-1045.
  102. Blum AK: Insulin use in pregnancy: an update. Diabetes Spectrum 2016, 29(2):92-97.
  103. Hessler KL, Dunemn K: Laboratory diagnosis of overt type 2 diabetes in the first trimester of pregnancy. Journal of the American Association of Nurse Practitioners 2017, 29(9):521-526.
  104. Wucher H, Lepercq J, Carette C, Colas C, Dubois-Laforgue D, Gautier J-F, Lalej D, Larger E, Ledoux S, Mbemba J: Poor prognosis of pregnancy in women with autoimmune type 1 diabetes mellitus masquerading as gestational diabetes. Diabetes & metabolism 2011, 37(1):47-51.
  105. Федерации ПМЗР. О совершенствовании пренатальной диагностики в профилактике наследственных и врожденных заболеваний у детей. от 28 декабря 2000 года N 457.
  106. Hadlock FP, Harrist R, Sharman RS, Deter RL, Park SK: Estimation of fetal weight with the use of head, body, and femur measurements—a prospective study. American journal of obstetrics and gynecology 1985, 151(3):333-337.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу